Literature DB >> 7789306

Regulation of glutamine:fructose-6-phosphate amidotransferase gene transcription by epidermal growth factor and glucose.

A J Paterson1, J E Kudlow.   

Abstract

In preparation for the cellular proliferation stimulated by growth factors, the rate of macromolecular synthesis must be increased to allow for the enlargement of the cell that proceeds mitosis. The increased glycoprotein synthesis that follows growth factor stimulation would consume the hexosamines required for protein modification. Glutamine:fructose-6-phosphate amidotransferase (GFAT) is the rate-limiting enzyme controlling the synthesis of the hexosamines used in these biosynthetic pathways. We tested the idea that growth factors might activate the transcription of the GFAT gene to increase the cellular content of this rate-limiting enzyme in hexosamine synthesis. We employed a human breast cancer cell line, MDA468 cells, which express high numbers of epidermal growth factor (EGF) receptors, to determine whether EGF could stimulate transcription of the GFAT gene. Our experiments showed that EGF stimulated the accumulation of GFAT messenger RNA (mRNA) to a level 4-fold higher than that in unstimulated cells. This accumulation could be largely accounted for by an increase in transcription, as assessed by nuclear run-on experiments. Furthermore, the GFAT mRNA was highly stable and not further stabilized by EGF. This effect of EGF on GFAT gene transcription required stimulation for 12-16 h with EGF. Interestingly, when cells were exposed to 25 mM glucose instead of 5 mM glucose, this effect of EGF was blocked. Glucose had no effect on the stability of the GFAT mRNA, implying that the effect of glucose was to antagonize the transcriptional effect of EGF on the GFAT gene. Glucosamine had an effect opposite that of glucose, in that it stimulated GFAT mRNA accumulation and had an additive effect with EGF on the accumulation of this mRNA. These results demonstrate that the GFAT gene undergoes a late transcriptional response to EGF and that the provision of high glucose concentrations to the cells blocks this EGF activation. This effect of glucose does not appear to result from its metabolism through GFAT to glucosamine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7789306     DOI: 10.1210/endo.136.7.7789306

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

1.  Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways.

Authors:  Yasuhito Onodera; Jin-Min Nam; Mina J Bissell
Journal:  J Clin Invest       Date:  2013-12-09       Impact factor: 14.808

Review 2.  O-GlcNAc signaling in the cardiovascular system.

Authors:  Gladys A Ngoh; Heberty T Facundo; Ayesha Zafir; Steven P Jones
Journal:  Circ Res       Date:  2010-07-23       Impact factor: 17.367

3.  Cloning and partial characterization of the mouse glutamine:fructose-6-phosphate amidotransferase (GFAT) gene promoter.

Authors:  P P Sayeski; D Wang; K Su; I O Han; J E Kudlow
Journal:  Nucleic Acids Res       Date:  1997-04-01       Impact factor: 16.971

4.  Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival.

Authors:  David L Masica; Rachel Karchin
Journal:  Cancer Res       Date:  2011-05-09       Impact factor: 12.701

Review 5.  O-GlcNAc and the cardiovascular system.

Authors:  Sujith Dassanayaka; Steven P Jones
Journal:  Pharmacol Ther       Date:  2013-11-25       Impact factor: 12.310

6.  Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway.

Authors:  J-M Zheng; J-M Zhu; L-S Li; Z-H Liu
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

7.  Noninferiority of 99mTc-Ethylenedicysteine-Glucosamine as an Alternative Analogue to 18F-Fluorodeoxyglucose in the Detection and Staging of Non-Small Cell Lung Cancer.

Authors:  Dong Dai; F David Rollo; Jerry Bryant; E Edmund Kim
Journal:  Contrast Media Mol Imaging       Date:  2018-03-15       Impact factor: 3.161

8.  O-GlcNAcylation: A New Cancer Hallmark?

Authors:  Yann Fardini; Vanessa Dehennaut; Tony Lefebvre; Tarik Issad
Journal:  Front Endocrinol (Lausanne)       Date:  2013-08-12       Impact factor: 5.555

9.  Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer.

Authors:  Fangfang Duan; Dongwei Jia; Junjie Zhao; Weicheng Wu; Lingqiang Min; Shushu Song; Hao Wu; Lan Wang; Hongshan Wang; Yuanyuan Ruan; Jianxin Gu
Journal:  Oncotarget       Date:  2016-06-21

Review 10.  The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring.

Authors:  Ferdinando Chiaradonna; Francesca Ricciardiello; Roberta Palorini
Journal:  Cells       Date:  2018-06-02       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.